Literature DB >> 35034954

CRISPR screening in human hematopoietic stem and progenitor cells reveals an enrichment for tumor suppressor genes within chromosome 7 commonly deleted regions.

Jeremy T Baeten1,2, Weihan Liu1,2, Isabelle C Preddy1,2, Ningxuan Zhou3, Megan E McNerney4,5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35034954      PMCID： PMC9064908          DOI： 10.1038/s41375-021-01491-z

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  15 in total

Review 1.  Next-Generation Machine Learning for Biological Networks.

Authors:  Diogo M Camacho; Katherine M Collins; Rani K Powers; James C Costello; James J Collins
Journal:  Cell       Date:  2018-06-07       Impact factor: 41.582

Review 2.  High-throughput functional genomics using CRISPR-Cas9.

Authors:  Ophir Shalem; Neville E Sanjana; Feng Zhang
Journal:  Nat Rev Genet       Date:  2015-04-09       Impact factor: 53.242

3.  Copy number alterations detected as clonal hematopoiesis of indeterminate potential.

Authors:  Koichi Takahashi; Feng Wang; Hagop Kantarjian; Xingzhi Song; Keyur Patel; Sattva Neelapu; Curtis Gumbs; Latasha Little; Samantha Tippen; Rebecca Thornton; Courtney D DiNardo; Farhad Ravandi; Carlos Bueso-Ramos; Jianhua Zhang; Xifeng Wu; Guillermo Garcia-Manero; P Andrew Futreal
Journal:  Blood Adv       Date:  2017-06-19

4.  Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition.

Authors:  Johan Tisserand; Konstantin Khetchoumian; Christelle Thibault; Doulaye Dembélé; Pierre Chambon; Régine Losson
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

5.  Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.

Authors:  Thomas Ernst; Andrew J Chase; Joannah Score; Claire E Hidalgo-Curtis; Catherine Bryant; Amy V Jones; Katherine Waghorn; Katerina Zoi; Fiona M Ross; Andreas Reiter; Andreas Hochhaus; Hans G Drexler; Andrew Duncombe; Francisco Cervantes; David Oscier; Jacqueline Boultwood; Francis H Grand; Nicholas C P Cross
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

6.  Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

Authors:  Hideki Makishima; Valeria Visconte; Hirotoshi Sakaguchi; Anna M Jankowska; Sarah Abu Kar; Andres Jerez; Bartlomiej Przychodzen; Manoj Bupathi; Kathryn Guinta; Manuel G Afable; Mikkael A Sekeres; Richard A Padgett; Ramon V Tiu; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-02-09       Impact factor: 22.113

7.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

Review 8.  The enigma of monosomy 7.

Authors:  Toshiya Inaba; Hiroaki Honda; Hirotaka Matsui
Journal:  Blood       Date:  2018-04-03       Impact factor: 22.113

9.  Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

Authors:  Marios Dimitriou; Petter S Woll; Teresa Mortera-Blanco; Mohsen Karimi; David C Wedge; Helen Doolittle; Iyadh Douagi; Elli Papaemmanuil; Sten Eirik W Jacobsen; Eva Hellström-Lindberg
Journal:  Oncotarget       Date:  2016-11-08

10.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Authors:  Benjamin L Ebert; Jennifer Pretz; Jocelyn Bosco; Cindy Y Chang; Pablo Tamayo; Naomi Galili; Azra Raza; David E Root; Eyal Attar; Steven R Ellis; Todd R Golub
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.